Drug Profile
Seocalcitol
Alternative Names: CB-1089; EB-1089Latest Information Update: 10 Dec 2015
Price :
$50
*
At a glance
- Originator LEO Pharma
- Developer Cougar Biotechnology; LEO Pharma
- Class Antineoplastics; Vitamin D analogues
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Liver cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 29 Mar 2010 Phase-I development is ongoing in USA
- 10 Jul 2009 Cougar Biotechnology has been acquired by Johnson and Johnson
- 07 May 2007 Phase-I clinical trials in Prostate cancer in USA (unspecified route)